News
News
- Biogen says Q4 revenue fell 22% to $2.85B
02/03/2021 / 13:07 - TeleTrader - BioCryst Announces FDA Approval of Supplemental New Drug Application for RAPIVAB® Expanding Patient Population to Include Children Six Months and Older
02/03/2021 / 13:00 - GlobeNewswire - Cassava Sciences’ Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study
02/02/2021 / 14:30 - GlobeNewswire - ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer’s/Amyloid Field
02/02/2021 / 14:30 - GlobeNewswire - Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
02/02/2021 / 14:00 - GlobeNewswire - Guide Dog Foundation Celebrates 75 Years Placing Guide Dogs With Individuals Who Are Blind or Visually Impaired
02/01/2021 / 17:59 - GlobeNewswire - Biogen Announces FDA Approval of PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Multiple Sclerosis
02/01/2021 / 13:30 - GlobeNewswire - Matinas BioPharma Announces Topline Results from ENHANCE-IT Study of LYPDISO™ Against Vascepa®
02/01/2021 / 12:00 - GlobeNewswire - Catalyst Biosciences Announces Closing of Public Offering of Common Stock
01/29/2021 / 22:01 - GlobeNewswire - Densely Packed Micronutrients Improve Metabolic Health, Research Goes Commercial
01/29/2021 / 15:44 - GlobeNewswire
Real-time